World Fabry Disease Epidemiology Forecast to 2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The “Fabry Disease - Epidemiology Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
Fabry Disease - Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Fabry Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data. The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.
Key Coverage and Benefits:The report includes the prevalent population and how will it change over the next eight years. Coverage of key Fabry Disease sub-populations and its prevalent or incident cases Prevalent or incident cases segmented by age and sex. The key differences in epidemiology patterns across the seven market segments.
Key Topics Covered:
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
4. Fabry Disease Overview
5. Risk Factors Associated with Fabry Disease
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
8. Prevalent & Incident Cases by 7 MM-2015-20259. Key Takeaways 10. Appendix For more information about this report visit https://www.researchandmarkets.com/research/64tzfg/world_fabry?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005416/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/11/2018 07:37 AM/DISC: 09/11/2018 07:38 AM